FDA Adverse Event Injury Summary report: N

AQUABEAM ROBOTIC SYSTEM

MDR report key: 11606516 · Received April 1, 2021

Report

Report Number
3012977056-2021-00016
Event Type
Injury
Date Received
April 1, 2021
Date of Event
March 10, 2021
Report Date
May 28, 2021
Manufacturer
PROCEPT BIOROBOTICS CORPORATION
Product Code
PZP
UDI-DI
B614AB20001
PMA / PMN Number
DEN170024
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

H.10 ADDITIONAL MANUFACTURER NARRATIVE: THE AQUABEAM ROBOTIC SYSTEM'S LOG FILE WAS REVIEWED, WHICH CONFIRMED NO MALFUNCTIONS DURING THE AQUABLATION PROCEDURE. THE REVIEW OF THE LOG FILE INDICATED THAT THE SYSTEM FUNCTIONED AS DESIGNED. A REVIEW OF THE DEVICE HISTORY RECORD (DHR) FOR AB2000-B REV G/SERIAL NUMBER (B)(6) WAS PERFORMED, WHICH CONFIRMED THAT NO NONCONFORMANCES WERE GENERATED DURING THE MANUFACTURING PROCESS OF THIS DEVICE. THE REVIEW INDICATED THAT THE DEVICE MET ALL REQUIRED SPECIFICATIONS UPON RELEASE FOR DISTRIBUTION. A REVIEW FOR SIMILAR COMPLAINTS UNDER AB2000-B REV G/LOT NUMBER (B)(6) CONFIRMED NO OTHER SIMILAR EVENTS. A REVIEW OF SIMILAR COMPLAINTS ACROSS ALL OTHER SYSTEMS CONFIRMED 20 OTHER SIMILAR EVENTS REPORTED TO PROCEPT BIOROBOTICS. THE AQUABEAM ROBOTIC SYSTEM'S INSTRUCTIONS FOR USE (IFU), IFU0104-00, REV. B, WAS REVIEWED AND STATES THE FOLLOWING: 4.3. WARNINGS: PROCEDURE AS WITH ANY SURGICAL UROLOGIC PROCEDURE, POTENTIAL PERIOPERATIVE RISKS OF THE AQUABLATION PROCEDURE INCLUDE: O BLEEDING A ROOT CAUSE FOR THE REPORTED EVENT COULD NOT BE DETERMINED. THE AQUABEAM ROBOTIC SYSTEM'S IFU LISTS BLEEDING AS A POTENTIAL RISK OF THE AQUABLATION PROCEDURE. BASED ON THE REVIEW OF THE LOG FILE, DHR AND IFU, THE EVENT IS CONSIDERED NOT TO BE DEVICE RELATED. SUBMISSION OF THIS REPORT DOES NOT CONSTITUTE AN ADMISSION THAT THE MANUFACTURER'S PRODUCT CAUSED OR CONTRIBUTED TO THE EVENT.

Additional Manufacturer Narrative · 1

THE PRODUCT IS NOT AVAILABLE FOR INVESTIGATION AS IT IS CURRENTLY IN USE AT THE USER FACILITY. INVESTIGATION BY MANUFACTURER IS CURRENTLY IN-PROCESS.

Description of Event or Problem · 1

A MALE PATIENT UNDERWENT AN AQUABLATION PROCEDURE FOR SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (BPH). PROCEPT BIOROBOTICS CORPORATION BECAME AWARE THAT POST-AQUABLATION PROCEDURE THE PATIENT WAS TAKEN BACK TO THE OPERATING ROOM (OR) DUE TO BLEEDING, WHICH WAS ADDRESSED BY PERFORMING CAUTERIZATION (PER MANUFACTURER'S INSTRUCTIONS FOR USE, BLEEDING IS A POTENTIAL PERIOPERATIVE RISK OF THE AQUABLATION PROCEDURE). THERE WERE NO ADVERSE HEALTH CONSEQUENCES REPORTED WITH THE PATIENT DUE TO THIS EVENT. NO MALFUNCTION OF THE AQUABEAM ROBOTIC SYSTEM WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
501974 AQUABEAM ROBOTIC SYSTEM FLUID JET REMOVAL SYSTEM PZP PROCEPT BIOROBOTICS CORPORATION AB2000 B614AB20001

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention